XML 63 R45.htm IDEA: XBRL DOCUMENT v3.25.2
Stock-Based Compensation (Tables)
12 Months Ended
Apr. 27, 2025
Summary of Time Based Restricted Stock Unit Activity

The following table summarizes the time-based restricted stock unit activity during fiscal years 2025, 2024, and 2023:

 

 

 

2025

 

 

2024

 

 

2023

 

 

 

Shares

 

 

Shares

 

 

Shares

 

outstanding at beginning of year

 

 

308,927

 

 

 

285,826

 

 

 

210,284

 

granted

 

 

91,629

 

 

 

174,753

 

 

 

119,687

 

vested (1)

 

 

(103,320

)

 

 

(151,652

)

 

 

(32,799

)

forfeited

 

 

(35,088

)

 

 

 

 

 

(11,346

)

outstanding at end of year

 

 

262,148

 

 

 

308,927

 

 

 

285,826

 

 

(1) During fiscal 2025, time-based restricted stock units totaling 103,320 vested at a fair value of $581,000, or $5.63 per share. During fiscal 2024, time-based restricted stock units totaling 151,652 vested at a fair value of $857,000, or $5.65 per share. During fiscal 2023, time-based restricted stock units totaling 32,799 vested at a fair value of $167,000, or $5.10 per share.

Summary of Assumptions Used to Determine Fair Value of Performance Based Restricted Stock Units

The following table provides assumptions used to determine the fair market value of the market-based total shareholder return component using the Monte Carlo simulation model on our outstanding performance-based restricted stock units granted to senior executives on August 8, 2024, January 8, 2024, September 28, 2023, and August 10, 2022:

 

 

 

August 8,

 

January 8,

 

September 28,

 

August 10,

 

 

2024

 

2024

 

2023

 

2022

Closing price of our common stock

 

$

4.65

 

 

$

5.61

 

 

$

5.59

 

 

$

5.06

 

Expected volatility of our common stock

 

 

35.0

%

 

 

33.5

%

 

 

37.3

%

 

 

48.2

%

Expected volatility of peer companies

 

 

22.6% - 104.0

%

 

 

33.7% - 102.6

%

 

 

35.7% - 91.5

%

 

 

41.6% - 105.1

%

Risk-free interest rate

 

 

3.90

%

 

 

4.30

%

 

 

4.90

%

 

 

3.13

%

Dividend yield

 

 

0.00

%

 

 

0.00

%

 

 

0.00

%

 

 

0.00

%

Correlation coefficient of peer companies

 

 

(0.01) - 0.17

 

 

 

0.01 - 0.21

 

 

 

0.01 - 0.21

 

 

 

0.05 - 0.23

 

Summary of Grants of Common Stock to Outside Directors

The following table summarizes information related to our grants of common stock to our outside directors during fiscal 2024 and 2023:

 

 

 

Common

 

 

(1)

 

 

 

 

 

Stock

 

 

Price Per

 

 

Vesting

Date of Grant

 

Awarded

 

 

Share

 

 

Period

July 3, 2023 - Fiscal 2024

 

 

16,616

 

 

$

5.04

 

 

Immediate

April 3, 2023 - Fiscal 2023

 

 

15,832

 

 

$

5.29

 

 

Immediate

January 3, 2023 - Fiscal 2023

 

 

17,819

 

 

$

4.70

 

 

Immediate

October 3, 2022 - Fiscal 2023

 

 

18,326

 

 

$

4.57

 

 

Immediate

July 1, 2022 - Fiscal 2023

 

 

19,753

 

 

$

4.24

 

 

Immediate

 

(1)
Price per share represents closing price of our common stock on the date of grant.
Performance Based Restricted Stock Units [Member]  
Summary of Vested Performance Based Restricted Stock Units The following table summarizes information related to our performance-based restricted stock units that vested during fiscal 2023.

 

 

 

 

 

 

(3)

 

 

(4)

 

 

 

 

Common

 

 

Weighted

 

 

Weighted

 

 

 

 

Stock Shares

 

 

Average

 

 

Average Price

 

 

Fiscal Year

 

Vested

 

 

Fair Value

 

 

Per Share

 

 

Fiscal 2023 (1)

 

 

545

 

 

$

3

 

 

$

5.10

 

 

Fiscal 2023 (2)

 

 

437

 

 

$

2

 

 

$

5.10

 

 

 

(1)
Performance-based restricted stock units vested for senior executives.
(2)
Performance-based restricted stock units vested for key employees.
(3)
Dollar amounts are in thousands.
(4)
Price per share is derived from the closing prices of our common stock on the dates the respective performance-based restricted stock units vested.
Senior Executives and Management [Member] | Time-Based Restricted Stock Units [Member]  
Summary of Grants of Time-Based Restricted Stock Unit Awards

The following table summarizes information related to our grants of time-based restricted stock unit awards associated with certain senior executives and key members of management during fiscal years 2025, 2024, and 2023:

 

 

 

Time-Based

 

 

(1)

 

 

 

 

 

Restricted Stock

 

 

Price

 

 

Vesting

Date of Grant

 

Units Awarded

 

 

Per Share

 

 

Period

January 6, 2025 (2)

 

 

21,506

 

 

$

5.69

 

 

3 years

September 26, 2024 (3)

 

 

46,823

 

 

$

5.98

 

 

1 year

August 8, 2024 (2)

 

 

23,300

 

 

$

4.65

 

 

3 years

January 8, 2024 (2)

 

 

14,758

 

 

$

5.61

 

 

31 months

September 28, 2023 (2)

 

 

100,067

 

 

$

5.59

 

 

34 months

September 28, 2023 (3)

 

 

59,928

 

 

$

5.59

 

 

1 year

September 6, 2022 (2)

 

 

37,671

 

 

$

4.58

 

 

1 to 3 years

August 10, 2022 (2)

 

 

82,016

 

 

$

5.06

 

 

35 months

 

(1)
Price per share represents the closing price of our common stock on the date the respective award was granted.
(2)
Time-based restricted stock units awarded to senior executives and key employees.
(3)
Time-based restricted stock units award to outside directors.
Executive officers and key employees [Member]  
Summary of Grants of Performance Based Restricted Stock Units

The following table summarizes information related to our grants of performance-based restricted stock units to our senior executives that were unvested as of April 27, 2025:

 

 

 

(1)

 

 

(2)

 

 

 

 

 

 

 

 

 

Performance-Based

 

 

Restricted Stock

 

 

 

 

 

 

 

 

 

Restricted Stock

 

 

Units Expected

 

 

 

 

 

 

 

Date of Grant

 

Units Awarded

 

 

to Vest

 

 

Price Per Share

 

 

 

Vesting Period

August 8, 2024

 

 

505,003

 

 

 

 

 

$

5.35

 

(3)

 

3 years

January 8, 2024

 

 

16,399

 

 

 

4,238

 

 

$

6.23

 

(4)

 

31 months

September 28, 2023

 

 

62,569

 

 

 

 

 

$

6.43

 

(5)

 

34 months

August 10, 2022

 

 

146,048

 

 

 

 

 

$

5.77

 

(6)

 

3 years

 

(1)
Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit award agreements as of the date of grant.
(2)
Compensation cost is based on an assessment each reporting period to determine the probability of whether or not certain performance targets will be met and how many shares are expected to be earned as of the end of the vesting period. These amounts represent the number of shares that are expected to vest as of April 27, 2025.
(3)
Price per share represents the fair market value per share ($1.15 per $1, or an increase of $0.70 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($4.65) for the performance-based component of the performance-based restricted stock units granted to senior executives on August 8, 2024.
(4)
Price per share represents the fair market value per share ($1.11 per $1, or an increase of $0.62 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($5.61) for the performance-based component of the performance-based restricted stock units granted to senior executives on January 8, 2024.
(5)
Price per share represents the fair market value per share ($1.15 per $1, or an increase of $0.84 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($5.59) for the performance-based component of the performance-based restricted stock units granted to senior executives on September 28, 2023.
(6)
Price per share represents the fair market value per share ($1.14 per $1, or an increase of $0.71 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($5.06) for the performance-based component of the performance-based restricted stock units granted to senior executives on August 10, 2022.